TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,343 | -41.8% | 70,620 | 0.0% | 0.00% | – |
| Q2 2023 | $1,084,723 | -18.7% | 70,620 | +19.0% | 0.00% | -100.0% |
| Q1 2023 | $1,334,107 | +6.9% | 59,320 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,247,500 | -14.7% | 59,320 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,462,000 | +1.7% | 59,333 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,438,000 | -6.0% | 59,333 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,529,000 | -16.8% | 59,320 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $1,838,000 | +28.0% | 59,220 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,436,000 | +54.9% | 59,220 | -6.8% | 0.00% | – |
| Q2 2021 | $927,000 | -73.6% | 63,520 | -54.8% | 0.00% | -100.0% |
| Q1 2021 | $3,513,000 | +102.9% | 140,680 | +121.5% | 0.00% | +100.0% |
| Q4 2020 | $1,731,000 | – | 63,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |